Octreotide in hepatocellular carcinoma.
Shouval
D
D
Liver Unit, Hadassah University Hospital, Jerusalem, Israel.
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D015282:Octreotide / Q000627:therapeutic use*; D013004:Somatostatin / Q000031:analogs & derivatives*
D018931:Antineoplastic Agents, Hormonal; D013004:Somatostatin; D015282:Octreotide